Alectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma.

Hironori SatohYusuke OkumaJumpei KashimaAya Konnno-YamamotoYasushi YatabeYuichiro Ohe

Published in: OncoTargets and therapy (2021)

We have reported a case of ALK-rearranged NSCLC with a miliary pulmonary metastasis pattern that was sensitive to alectinib and in which the serum amylase level decreased in response to treatment with alectinib. Young patients with miliary pulmonary metastasis should be checked for all driver mutations.

Keyphrases

advanced non small cell lung cancer
pulmonary hypertension
small cell lung cancer
epidermal growth factor receptor
replacement therapy